Igen/Roche-Boehringer Mannheim Seeking To Resolve Suit In Upcoming Talks
This article was originally published in The Gray Sheet
A July 28 preliminary injunction barring Roche-Boehringer Mannheim's distribution to the physician-office market of the Elecsys line of immunoassay analyzers incorporating Igen's Origen technology should strengthen Igen's position in discussions with Roche aimed at settling the firms' dispute over a 1992 licensing agreement.
You may also be interested in...
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.
Belgian developer of cancer diagnostics is building an infectious disease portfolio on the back of its new SARS-CoV-2 test and collaborations with Immunexpress and Endpoint Health.